WWMR Announces Pain Clinic Physicians' Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharm...( SAN FRANCISCO Nov. 20 /- WWMR Inc. th...)

SAN FRANCISCO, Nov. 20 /PRNewswire/ -- WWMR, Inc., the marketing research leader in pain, announces results of the first annual "Most Appreciated Pain Drug Company Survey". The top three most appreciated companies are Pfizer, Eli Lilly and Endo Pharmaceuticals, according to the 100 pain clinic physicians surveyed in September 2008. These companies are most noted for their knowledgeable, respectful and informed sales representatives, their sampling/voucher plans, and their educational resources, as well as their drug products.

"While Pfizer, Lilly and Endo may be the most appreciated companies among many of the surveyed pain clinicians, there is plenty of opportunity for others to enhance their company image," stated Susan Olsen, President of WWMR, Inc. "A notable proportion of the pain clinicians surveyed noted that they don't appreciate any pain drug companies, and we view this is an opportunity waiting." Clients subscribing to the Pain Clinic Monitor have full access to this company image information, which outlines opportunities for companies to develop positive relationships with clinicians, and profiles competing companies.

Launched in January 2008, the Pain Clinic Monitor provides deep insights into the treatment of pain clinic-based chronic pain patients. The Pain Clinic Monitor provides a long-awaited perspective on the treatment of more than 10,000 patients with 27 different pain conditions. Information is available on in-office treatments as well as on up to seven pain drugs a patient has been prescribed, including why prescribed drugs have been tried, switched and discontinued.

The Pain Clinic Monitor is a monthly audit of a carefully balanced sample of 100 academic and nonacademic, office-based pain clinics, with each reporting treatment details for 10 patients. It is the basis for the 27 pain condition profiles provided as part of the Monitor. Companies, drug products and detai
'/>"/>